Universal prestorage leukocyte reduction

被引：0

作者：

McDonald, CE ^{[1
]}

机构：

[1] Portland VA Med Ctr, Dept Pathol & Lab Med, Portland, OR 97207 USA

来源：

LABORATORY MEDICINE | 2001年 / 32卷 / 12期

关键词：

D O I：

10.1309/9CVH-YUKB-FQ4D-A58F

中图分类号：

R446 [实验室诊断]; R-33 [实验医学、医学实验];

学科分类号：

1001 ;

摘要：

引用

页码：756 / 757

页数：2

共 14 条

[1] Practical guidelines for process validation and process control of white cell-reduced blood components: Report of the biomedical excellence for safer transfusion (BEST) working party of the international society of blood transfusion (ISBT)
Dumont, LJ
Dzik, WH
Rebulla, P
Brandwein, H
[J]. TRANSFUSION, 1996, 36 (01) : 11 - 20
[2] Leukocyte reduction of blood components: Public policy and new technology
Dzik, S
Aubuchon, J
Jeffries, L
Kleinman, S
Manno, C
Murphy, MF
Popovsky, MA
Sayers, M
Silberstein, LE
Slichter, SJ
Vamvakas, EC
[J]. TRANSFUSION MEDICINE REVIEWS, 2000, 14 (01) : 34 - 52
[3] The use and quality control of leukocyte-depleted cell concentrates
Engelfriet, CP
Reesink, HW
[J]. VOX SANGUINIS, 1998, 75 (01) : 82 - 83
[4] PREVALENCE OF PLATELET TRANSFUSION REACTIONS BEFORE AND AFTER IMPLEMENTATION OF LEUKOCYTE-DEPLETED PLATELET CONCENTRATES BY FILTRATION
GOODNOUGH, LT
RIDDELL, J
LAZARUS, H
CHAFEL, TL
PRINCE, G
HENDRIX, D
YOMTOVIAN, R
[J]. VOX SANGUINIS, 1993, 65 (02) : 103 - 107
[5] The case against universal WBC reduction (and for the practice of evidence-based medicine)
Goodnough, LT
[J]. TRANSFUSION, 2000, 40 (12) : 1522 - 1527
[6] POSTOPERATIVE INFECTION AND NATURAL-KILLER-CELL FUNCTION FOLLOWING BLOOD-TRANSFUSION IN PATIENTS UNDERGOING ELECTIVE COLORECTAL SURGERY
JENSEN, LS
ANDERSEN, AJ
CHRISTIANSEN, PM
HOKLAND, P
JUHL, CO
MADSEN, G
MORTENSEN, J
MOLLERNIELSEN, C
HANBERGSORENSEN, F
HOKLAND, M
[J]. BRITISH JOURNAL OF SURGERY, 1992, 79 (06) : 513 - 516
[7] Randomised comparison of leucocyte-depleted versus buffy-coat-poor blood transfusion and complications after colorectal surgery
Jensen, LS
KissmeyerNielsen, P
Wolff, B
Qvist, N
[J]. LANCET, 1996, 348 (9031) : 841 - 845
[8] Laupacis Andreas, 2001, Transfusion (Bethesda), V41, P560, DOI 10.1046/j.1537-2995.2001.41040560.x
[9] Hypotensive reactions associated with platelet transfusions and angiotensin-converting enzyme inhibitors
Mair, B
Leparc, GF
[J]. VOX SANGUINIS, 1998, 74 (01) : 27 - 30
[10] New variant Creutzfeldt-Jakob Disease (nvCJD): The risk of transmission by blood transfusion and the potential benefit of leukocyte-reduction of blood components
Murphy, MF
[J]. TRANSFUSION MEDICINE REVIEWS, 1999, 13 (02) : 75 - 83

← 1 2 →